Other languages INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
0.929 ^USD	-5.69%		-23.85%	-31.19%

Apr. 18	Top Premarket Decliners	MT
Apr. 17	Sector Update: Health Care Stocks Retreating Late Afternoon	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

INVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16
NAYA Biosciences Inc. Announces Publication of New Data for its CD38-targeted Flex-NK Bispecific Antibody in the American Society of Hematology's Blood Journal	Dec. 11
Top Premarket Gainers	Nov. 14
INVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Wall Street Set to Open Slightly Higher as Investors Parse Powell Remarks	Nov. 10
Sector Update: Health Care Stocks Softer Late Afternoon	23-10-23
Sector Update: Health Care Stocks Mixed in Monday Afternoon Trading	23-10-23
INVO Bioscience Shares Skyrocket After Signing Deal to Buy NAYA Biosciences	23-10-23
Wall Street Set to Open Lower Monday as National Activity Index Shows Near-Historic Economic Growth	23-10-23
INVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
INVO Bioscience Closes Wisconsin Fertility Institute Acquisition	23-08-11
Top Midday Decliners	23-08-04
INVO Bioscience, Inc. Receives 510(K) FDA Clearance for Expanded Use of the Invocell Device	23-06-27
INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
INVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17
INVO Bioscience, Inc. Auditor Raises 'Going Concern' Doubt	23-04-16
INVO Bioscience, Inc. Announces Resignation of Jeffrey Segal as A Director	23-04-04
INVO Bioscience, Inc. Provides Earnings Guidance for the Fourth Quarter and Year Ended December 31, 2022	23-03-30
INVO Bioscience Closes $3 Million Registered Direct Offering	23-03-28
Sector Update: Health Care Stocks Higher in Late Afternoon Trading	23-03-24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Other languages

Filters